Medications

Capping copays will raise premiums, up drug prices

(HealthDay)—The proposed capping of copays will raise premiums and is likely to increase drug prices, according to a report from the National Center for Policy Analysis (NCPA).

Medications

EpiPen's pricing debacle and its impact on patients, insurers

A firestorm erupted this week in response to the pharmaceutical company Mylan's steep increase in the price of its EpiPen, a life-saving treatment for severe allergic reactions, with consumers and politicians expressing outrage ...

Medications

Pediatric allergist discusses EpiPen controversy

Members of Congress are calling for an investigation into the EpiPen maker Mylan. The pharmaceutical company has increased the price of EpiPens, from about $100 in 2008 to more than $500 today.

Medications

Advocates hope shaming drugmakers discourages price spikes

Frustrated by the rising cost of prescription drugs, California health advocates hope sunlight and a dose of shame will discourage drugmakers from raising their prices too quickly or introducing new medications at prices ...

page 31 from 40